Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity

Published:2011-07-27 Issue:6 Volume:72 Page:661-667
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Makhov Peter,Golovine Konstantin,Canter Daniel,Kutikov Alexander,Simhan Jay,Corlew Melany M.,Uzzo Robert G.,Kolenko Vladimir M.

Funder

National Institutes of Health Grants

American Institute for Cancer Research Grant

Department of Defense Physician Research Training Award

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.21469/fullpdf

Reference26 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Docetaxel-mediated apoptosis in myeloid progenitor TF-1cells is mitigated by zinc: Potential implication for prostate cancer therapy;Makhov;Prostate,2011

3. Potential for improvement of docetaxel-based chemotherapy: A pharmacological review;Engels;Br J Cancer,2005

4. Clinical pharmacokinetics of docetaxel: Recent developments;Baker;Clin Pharmacokinet,2006

5. Clinical pharmacokinetics of docetaxel;Clarke;Clin Pharmacokinet,1999

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic enhancement: Exploring the potential of piperine in cancer therapeutics through chemosensitization and combination therapies;Life Sciences;2024-10

2. Molecular Evidence of the Bio-activities of Traditional Home Medicine Ingredients;Current Topics in Medicinal Chemistry;2024-07-02

3. Chitosan-coated MIL-100(Fe) nanoparticles for enhanced piperine release in breast cancer treatment;Journal of Molecular Structure;2024-06

4. In vitro modulation the Notch pathway by piperine: A therapeutic strategy for docetaxel‐resistant and non‐resistant prostate cancer;Chemical Biology & Drug Design;2024-06

5. Role of Cytochrome P450 3A4 in Cancer Drug Resistance: Challenges and Opportunities;Current Drug Metabolism;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3